Proov
Paul Suchoski is a seasoned professional with extensive experience in leadership and innovation across various sectors. Currently serving on the Board of Directors at Syght and as an Advisory Board Member at Proov Test by MFB Fertility, Inc., Paul has previously held the position of Chief Operating Officer at Secure Medication Systems, LLC, where efforts focused on combating opioid overdoses through safe medication dispensing solutions. Additionally, Paul contributed to the educational field as a volunteer teacher at Holy Trinity Episcopal Academy, mentoring students in entrepreneurship. Notably, Paul was the CEO of Optium Corporation, where successful fundraising efforts garnered over $50 million in venture capital, and served as Vice President at JDS Uniphase, following the acquisition of his company. Paul holds a Ph.D. in Electrical Engineering from the University of Florida, completed between 1978 and 1986.
This person is not in any teams
This person is not in any offices
Proov
2 followers
Proov offers a suite of in vitro diagnostics to provide fertility insights throughout the entire menstrual cycle. When paired with the free Proov Insight app, Proov's easy, at-home pee tests provide a science-backed fertility coach right in your hand. First, a woman can measure all of the menstrual hormones daily with Proov tests, then snap a photo of each test within the Insight app. Then, a woman can follow the in-app prompts throughout her cycle to understand ovulation status, get daily insights and an Ovulation Insights score. Finally, the app generates a personalized action plan to maximize her wellness or develop a fertility strategy. Proov was founded by Amy Beckley, Ph.D, the "infertile scientist," after three years of infertility and seven miscarriages. Amy applied her own science expertise to uncover a luteal phase defect (a problem with ovulation quality). With help from her doctor and a simple supplement, Amy was able to get pregnant with her daughter. Proov is a venture capital backed company and the leader in understanding hormone health on the basis of tracking PdG, a metabolite of progesterone.